USRM has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
USRM has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the average growth rate of total revenue estimates over a 3-year to 5-year period.
As of today, US Stem Cell's Total Revenue Growth Rate (Future 3Y To 5Y Est) is N/A.
For the Biotechnology subindustry, US Stem Cell's Total Revenue Growth Rate (Future 3Y To 5Y Est), along with its competitors' market caps and Total Revenue Growth Rate (Future 3Y To 5Y Est) data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Biotechnology industry and Healthcare sector, US Stem Cell's Total Revenue Growth Rate (Future 3Y To 5Y Est) distribution charts can be found below:
* The bar in red indicates where US Stem Cell's Total Revenue Growth Rate (Future 3Y To 5Y Est) falls into.
US Stem Cell (OTCPK:USRM) Total Revenue Growth Rate (Future 3Y To 5Y Est) Explanation
Total Revenue Growth Rate (Future 3Y To 5Y Est) is the growth rate of total revenue estimates over a 3-year to 5-year period. This data is provided directly by our trusted data vendors Refinitiv or Morningstar.
In situations where both vendors do not directly provide the growth rate data, we use the most recent annual revenue for the current year and estimated future revenue figures provided by the vendor to calculate the growth rate. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average total revenue estimates growth rate.
Thank you for viewing the detailed overview of US Stem Cell's Total Revenue Growth Rate (Future 3Y To 5Y Est) provided by GuruFocus.com. Please click on the following links to see related term pages.
Murphy William P Jr | director | 13794 NW 4TH STREET, SUITE 212, SUNRISE FL 33325 |
Gregory Knutson | director | 14855 ABERDEN STREET NE, HAM LAKE MN 55304 |
Mark P Borman | director | 5240 WASHBURN AVENUE SOUTH, MINNEAPOLIS MN 55410 |
Charles A Hart | director | 19345 RHINESTONE STREET NW, ANOKA MN 55303 |
Sheldon T. Anderson | director | 1121 CRANDON BLVD., APT. D-103, KEY BISCAYNE FL 33149 |
Kristin C Comella | officer: Chief Science Officer | 1310 LEEWARD WAY, WESTON FL 33327 |
A Jones Lee | director | 54 LOCKE LAKE RD, FRIDLEY MN 55432 |
Karl Groth | director | 1160 FIFTH AVENUE, SUITE 207, NEW YORK NY 10029 |
Matthew J Fendrich | officer: Vice President,Sales&Marketing | 482 PEACOCK LANE SOUTH, JUPITER FL 33458 |
Alan P Timmins | director | 1111 MAIN STREET, SUITE 600, VANCOUVER WA 98660 |
Bruce C Carson | director | 11850 COTTONWOOD STREET NW, COON RAPIDS MN 55448 |
Howard J Leonhardt | director, 10 percent owner, officer: Executive Chairman & CTO | 13794 NW 4TH STREET, SUITE 212, SUNRISE FL 33325 |
Bromley R Scott | officer: VP of Public Relations | 13794 NW 4TH STREET, SUITE 212, SUNRISE FL 33325 |
Richard Iii Spencer | director | 13794 NW 4TH STREET, SUITE 212, SUNRISE FL 33325 |
Mike Tomas | director | 13794 NW 4TH STREET, SUITE 212, SUNRISE FL 33325 |
From GuruFocus
By PRNewswire PRNewswire • 05-08-2018
By PRNewswire PRNewswire • 08-10-2019
By PRNewswire PRNewswire • 01-15-2019
By PRNewswire PRNewswire • 03-14-2019
By ACCESSWIRE ACCESSWIRE • 03-09-2022
By PRNewswire PRNewswire • 09-11-2018
By PRNewswire PRNewswire • 11-08-2018
By PRNewswire PRNewswire • 05-17-2018
By PRNewswire PRNewswire • 08-08-2019
By ACCESSWIRE ACCESSWIRE • 06-08-2021
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.